Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Aromatase Inhibitor Responsiveness in Endometrial Carcinoma

NCT00997373 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT00997373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00997373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Aromatase Inhibitor Responsiveness in Endometrial Carcinoma
Lead sponsor
University of California, Davis
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2009
Completion date
September 30, 2013
Enrollment
43 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial carcinoma